MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison

University Hospital, Angers

Status: Completed

Conditions: Hepatocellular Carcinoma

Treatments: Diagnostic Test: MRI diagnostic

Study type: Observational

Funder types: Other

Identifiers

NCT04652947

2018-74

Details and patient eligibility

About

Compare diagnostic MRI performance of gadoteric acid, gadoxetic acid and P03277 for suspected CHC nodules less than 3 cm, using LIRADS criteria

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who had all three MRI scans as part of the diagnosis of the same suspected CHC lesion(s)
• Reference diagnosis obtained for suspected CHC nodules by a diagnostic algorithm taking into account histology, imaging and follow-up

Exclusion criteria

• Delay between first MRI and 3rd MRI greater than 3 months